Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04130490 · ClinicalTrials.gov registry record
The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study
A clinical trial of Cataract and Healthy Eye, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 176
- Enrollment target
- 1
- Study location
NCT04130490: Completed study of Cataract and Healthy Eye, sponsored by Heidelberg Engineering.
NCT04130490 is a study of Cataract and Healthy Eye that has completed, run by Heidelberg Engineering. The registered enrollment target is 176 participants, below the 226-participant average among 83 other Cataract trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04130490, a study of Cataract and Healthy Eye, has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment parameters with the ANTERION
Primary Outcome
Reproducibility, repeatability and agreement of Anterior Corneal Topography parameters (3mm ring) of ANTERION and the reference device
Conditions Studied
Interventions
- DEVICE ANTERION
Study Locations (1)
New York
- State University of New York College of Optometry - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2023-12-30 |
What the finished NCT04130490 record still lists
NCT04130490 is an observational study that tracks outcomes without assigning an intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 226-participant average among 83 other Cataract trials with a reported enrollment target (22% lower).
The record links to 5 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which ANTERION is the first listed.
NCT04130490 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04130490 about?
NCT04130490 is a clinical study titled "The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study". This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment parameters with the ANTERION
What is the current status of trial NCT04130490?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2019-10-11. Estimated completion is 2023-12-30.
What conditions does trial NCT04130490 study?
This clinical trial studies the following conditions: Cataract, Healthy Eye, Cornea Abnormality, Post-Keratorefractive Surgery, IOL.
What interventions are being tested in trial NCT04130490?
The interventions under investigation include: ANTERION (DEVICE).
Who is sponsoring clinical trial NCT04130490?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04130490 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04130490's enrollment target sits among peer trials
176 29th of 83 higher than 55 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03304821 · 176 participants · Phase 2
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
- NCT03447938 · 176 participants · NA
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- NCT03824145 · 176 participants · NA
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
- NCT04177914 · 176 participants · Phase 3
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI